However, to our surprise, we found that the RNA-OG/peptide-K10 with a low level of peptide, i.e., RNA-OG/peptide-K10low, resulted in better protective anti-tumor immunity than the RNA-OG/peptide-K10 with a high peptide load, i.e., RNA-OG/pOVA-K10high (Figure 3). This evidence concerns the gene KRT10 and neoplasm.